HEALTH TECHNOLOGY ASSESSMENT DECISIONS FOR PAIN THERAPIES: RESULTS, RATIONALES, AND TRENDS

被引：0
|
作者：
Gittings, K. [1 ]
Kanaskar, A. [2 ]
Campbell, D. [1 ]
Riggs, K. [1 ]
Meyer, K. L. [1 ]
机构：
[1] Xcenda, Palm Harbor, FL USA
[2] Xcenda, Tampa, FL USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.1340
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND67
引用
收藏
页码：S282 / S282
页数：1
相关论文
共 50 条
  • [41] The implementation of health technology assessment principles in public decisions concerning orphan drugs
    Elenka Brenna
    Barbara Polistena
    Federico Spandonaro
    European Journal of Clinical Pharmacology, 2020, 76 : 755 - 764
  • [42] 2015 UPDATE OF HEALTH TECHNOLOGY ASSESSMENT DECISIONS ACROSS THE GLOBE: A FOCUS ON ONCOLOGY
    Clark, R. S.
    Campbell, C. M.
    Meyer, K. L.
    Bramley, T. J.
    VALUE IN HEALTH, 2016, 19 (03) : A6 - A6
  • [43] REVIEW OF THE DECISIONS OF HEALTH TECHNOLOGY ASSESSMENT AGENCIES FOR CAPECITABINE FOR THE TREATMENT OF BREAST CANCER
    Saggia, M. G.
    Borges, L. G.
    VALUE IN HEALTH, 2009, 12 (07) : A289 - A289
  • [44] The implementation of health technology assessment principles in public decisions concerning orphan drugs
    Brenna, Elenka
    Polistena, Barbara
    Spandonaro, Federico
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (06) : 755 - 764
  • [45] AN ANALYSIS OF NICE RECOMMENDED IN LINE WITH CLINICAL PRACTICE HEALTH TECHNOLOGY ASSESSMENT DECISIONS
    O'Neill, P.
    Chapman, A. M.
    Devlin, N.
    VALUE IN HEALTH, 2015, 18 (03) : A95 - A95
  • [46] 2018 UPDATE OF HEALTH TECHNOLOGY ASSESSMENT DECISIONS ACROSS THE GLOBE: A FOCUS ON ONCOLOGY
    Clark, R. S.
    Gittings, K.
    Campbell, C.
    Meyer, K.
    VALUE IN HEALTH, 2018, 21 : S48 - S48
  • [47] Limitations of traditional health technology assessment methods and implications for the evaluation of novel therapies
    Doctor, Jason
    MacEwan, Joanna P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (09) : 1635 - 1642
  • [48] Regulatory and health technology assessment of cell and gene therapies in Europe: Convergence or divergence?
    Hoogendoorn, Mark
    Fabriek, Babs
    Bloem, Lourens T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 16 - 16
  • [49] HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT FOR SELECT ONCOLOGY THERAPIES IN EUROPEAN MAJOR MARKETS
    Koka, N. S.
    Syed, A. A.
    Ahmad, M.
    Patel, K.
    Nair, S.
    Shah, S.
    VALUE IN HEALTH, 2022, 25 (12) : S329 - S329
  • [50] HEALTH TECHNOLOGY ASSESSMENT (HTA) REVIEW OF CELL & GENE THERAPIES: THE ROAD TO REIMBURSEMENT
    Vu, B. K.
    Forsythe, A.
    Nguyen, K.
    Tomaras, D.
    VALUE IN HEALTH, 2020, 23 : S20 - S20
12345